Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma

Journal of Surgical Oncology

Volumn 110, Issue 7, 2014, Pages 888-892

  Cloyd, Jordan M ^a   Wapnir, Irene L ^a   Read, Blake M ^a   Swetter, Susan ^a   Greco, Ralph S ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

indocyanine green; isosulfan blue; lymphadenectomy; melanoma; nuclear medicine; sentinel lymph node biopsy

Indexed keywords

INDOCYANINE GREEN; ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M; COLORING AGENT; FUCHSINE; ISO-SULFAN BLUE; RADIOPHARMACEUTICAL AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CUTANEOUS MELANOMA; FEMALE; FLUORESCENCE ANGIOGRAPHY; FLUORESCENCE LYMPHANGIOGRAPHY; HUMAN; HUMAN TISSUE; INDOCYANINE GREEN ANGIOGRAPHY; LYMPHANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA METASTASIS; PERITUMORAL DRUG ADMINISTRATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; CANCER STAGING; DIAGNOSTIC USE; FLUORESCENCE; FOLLOW UP; LYMPH NODE; LYMPHOSCINTIGRAPHY; MELANOMA; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; SKIN NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLORING AGENTS; FEMALE; FLUORESCENCE; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; LYMPH NODES; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TECHNETIUM TC 99M SULFUR COLLOID; YOUNG ADULT;

EID: 84922279056     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23745     Document Type: Article

References (32)

1. Morton DL, Wanek L, Nizze JA, et al.,: Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991; 214: 491-499 discussion 499-501.
2. Balch CM, Soong SJ, Gershenwald JE, et al.,: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol Off J Am Soc Clin Oncol 2001; 19: 3622-3634.
3. Morton DL, Thompson JF, Cochran AJ, et al.,: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317. doi: 10.1056/NEJMoa060992
4. Gershenwald JE, Tseng CH, Thompson W, et al.,: Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery 1998; 124: 203-210.
5. Morton DL, Cochran AJ, Thompson JF, et al.,: Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005; 242: 302-311 discussion 311-313.
6. Carlson GW, Page AJ, Cohen C, et al.,: Regional recurrence after negative sentinel lymph node biopsy for melanoma. Ann Surg 2008; 248: 378-386. doi: 10.1097/SLA.0b013e3181855718
7. Van der Vorst JR, Schaafsma BE, Verbeek FPR, et al.,: Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol 2012; 19: 4104-4111. doi: 10.1245/s10434-012-2466-4
8. Schaafsma BE, Verbeek FPR, Rietbergen DDD, et al.,: Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg 2013; 100: 1037-1044. doi: 10.1002/bjs.9159
9. Fujiwara M, Mizukami T, Suzuki A, et al.,: Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: Preliminary experience. J Plast Reconstr Aesthetic Surg 2009; 62: e373-378. doi: 10.1016/j.bjps.2007.12.074
10. Hayashi T, Furukawa H, Oyama A, et al.,: Sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in cutaneous head and neck/lip mucosa melanomas. Head Neck 2012; 34: 758-761. doi: 10.1002/hed.21651
11. Namikawa K, Yamazaki N:, Sentinel lymph node biopsy guided by indocyanine green fluorescence for cutaneous melanoma. Eur J Dermatol 2011; 21: 184-190. doi: 10.1684/ejd.2010.1237
12. Gilmore DM, Khullar OV, Gioux S, et al.,: Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol 2013; 20: 2357-2363. doi: 10.1245/s10434-013-2905-x
13. Balch CM, Soong S, Ross MI, et al.,: Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000; 7: 87-97.
14. Morton DL, Wen DR, Wong JH, et al.,: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (Chicago IL) 1960; 1992; 127: 392-399.
15. Albertini JJ, Cruse CW, Rapaport D, et al.,: Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-224.
16. Wapnir I, Dua M, Kieryn A, et al.,: Intraoperative imaging of nipple perfusion patterns and ischemic complications in nipple-sparing mastectomies. Ann Surg Oncol 2014; 21: 100-106. doi: 10.1245/s10434-013-3214-0
17. Kitai T, Inomoto T, Miwa M, et al.,: Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer Tokyo Jpn 2005; 12: 211-215.
18. Troyan SL, Kianzad V, Gibbs-Strauss SL, et al.,: The FLARE intraoperative near-infrared fluorescence imaging system: A first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 2009; 16: 2943-2952. doi: 10.1245/s10434-009-0594-2
19. Van der Vorst JR, Schaafsma BE, Verbeek FPR, et al.,: Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma. Br J Dermatol 2013; 168: 93-98. doi: 10.1111/bjd.12059
20. Jain V, Phillips BT, Conkling N, et al.,: Sentinel lymph node detection using laser-assisted indocyanine green dye lymphangiography in patients with melanoma. Int J Surg Oncol 2013; 2013: 904-907.
21. Namikawa K, Tsutsumida A, Tanaka R, et al.,: Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma. Int J Clin Oncol 2014; 19: 198-203. doi: 10.1007/s10147-013-0524-y
22. Brouwer OR, Buckle T, Vermeeren L, et al.,: Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: A validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med Off Publ Soc Nucl Med 2012; 53: 1034-1040. doi: 10.2967/jnumed.112.103127
23. Liu Y, Truini C, Ariyan S:, A randomized study comparing the effectiveness of methylene blue dye with lymphazurin blue dye in sentinel lymph node biopsy for the treatment of cutaneous melanoma. Ann Surg Oncol 2008; 15: 2412-2417. doi: 10.1245/s10434-008-9953-7
24. Zengel B, Yararbas U, Sirinocak A, et al.,: Sentinel lymph node biopsy in breast cancer: Review on various methodological approaches. Tumori 2013; 99: 149-153. doi: 10.1700/1283.14184
25. Lin KM, Patel TH, Ray A, et al.,: Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. J Am Coll Surg 2004; 199: 561-566. doi: 10.1016/j.jamcollsurg.2004.06.018
26. Mieog JSD, Troyan SL, Hutteman M, et al.,: Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 2011; 18: 2483-2491. doi: 10.1245/s10434-011-1566-x
27. Hutteman M, Mieog JSD, van der Vorst JR, et al.,: Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat 2011; 127: 163-170. doi: 10.1007/s10549-011-1419-0
28. Korn JM, Tellez-Diaz A, Bartz-Kurycki M, et al.,: Indocyanine green SPY elite-assisted sentinel lymph node biopsy in cutaneous melanoma. Plast Reconstr Surg 2014; 133: 914-922. doi: 10.1097/PRS.0000000000000006
29. Fujisawa Y, Nakamura Y, Kawachi Y, et al.,: Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer. J Surg Oncol 2012; 106: 41-45. doi: 10.1002/jso.23045
30. Tagaya N, Yamazaki R, Nakagawa A, et al.,: Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 2008; 195: 850-853. doi: 10.1016/j.amjsurg.2007.02.032
31. Jung S-Y, Kim S-K, Kim SW, et al.,: Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: A randomized controlled trial. Ann Surg Oncol 2014; 21: 1254-1259. doi: 10.1245/s10434-013-3437-0
32. Murawa D, Polom K, Murawa P:, One-year postoperative morbidity associated with near-infrared-guided Indocyanine Green (ICG) or ICG in conjugation with Human Serum Albumin (ICG:HSA) sentinel lymph node biopsy. Surg Innov 2013; 21: 240-243.